InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Bush Jennifer. Director active across 1 company, notably Artiva Biotherapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 12 September 2024. The latest transaction was disclosed on 26 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations